ID CLB HC.PH.BIO.CLB
Develops drugs, biologics or cell and gene therapies with no approved product on the market (no revenue, or milestones only); such a developer is here, not in contract research.
Sector, group and industry above this class, as placed in the current release. The sector and the industry link to their companies.
Companies whose primary class this is. The sector and industry pages and the screener count them the same way.
| Company | Ticker | Country | Market cap | Filings |
|---|---|---|---|---|
| FullHope Biomedical Co., Ltd. | 7773 | Taiwan | — | 36 |
| BIOTECHNICA INTERNATIONAL INC Delisted | — | United States of America | — | 35 |
| Polaryx Therapeutics, Inc. | PLYX | United States of America | — | 35 |
| Ecopia BioSciences Inc. Delisted | EIA | Canada | — | 34 |
| GENETICS INSTITUTE INC Delisted | — | United States of America | — | 34 |
| METiS TechBio Co., Ltd | — | China | — | 33 |
| Xenetic Biosciences PLC Delisted | — | United Kingdom | — | 33 |
| Cambridge Antibody Technology Group Delisted | — | United Kingdom | — | 32 |
| Chemokine Therapeutics Corp. Delisted | CHKT | Canada | — | 32 |
| Kineta, Inc. Delisted | KANT | United States of America | — | 32 |
| Obsidian Therapeutics, Inc. | — | United States of America | — | 32 |
| Apnimed, Inc. | — | United States of America | — | 31 |
| Herantis Pharma Oyj | HRTIS | Finland | — | 31 |
| Latigo Biotherapeutics, Inc. | — | United States of America | — | 31 |
| Nventa Biopharmaceuticals Corporation Delisted | NVN | Canada | — | 31 |
| Quadrant Healthcare Delisted | — | United Kingdom | — | 31 |
| Sr Pharma Delisted | — | United Kingdom | — | 31 |
| VIRUS RESEARCH INSTITUTE INC Delisted | — | United States of America | — | 31 |
| 株式会社ＵＭＮファーマ Delisted | 4585 | Japan | — | 31 |
| Destiny Pharma PLC Delisted | DEST | United Kingdom | — | 30 |
| HJ Science Co., Ltd. | — | Hong Kong | — | 30 |
| LTT Bio-Pharma Co., Ltd. Delisted | — | Japan | — | 30 |
| Neutec Pharma Delisted | — | United Kingdom | — | 30 |
| Redx Pharma Plc Delisted | REDX | United Kingdom | — | 30 |
| Shaanxi Micot Pharmaceutical Technology Co., Ltd. | — | Hong Kong | — | 30 |
| IMBiologics Corp. | 493280 | South Korea | — | 29 |
| ALLERGAN LIGAND RETINOID THERAPEUTICS INC Delisted | — | United States of America | — | 28 |
| BIONET Therapeutics Corp. | 7808 | Taiwan | — | 28 |
| Cardiogeni Plc | — | United Kingdom | — | 28 |
| e-therapeutics plc Delisted | ETX | United Kingdom | — | 28 |
| Premier Veterinary Group plc Delisted | PVG | United Kingdom | — | 28 |
| RIBOGENE INC / CA/ Delisted | — | United States of America | — | 28 |
| Biophage Pharma Inc. Delisted | BIPMF | Canada | — | 27 |
| Vogenx, Inc. | — | United States of America | — | 27 |
| Brainstorm Cell Therapeutics Inc | BCLI | United States of America | — | 26 |
| Infinity Pharmaceuticals Inc Delisted | INFI | United States of America | — | 26 |
| THERAPEUTIC DISCOVERY CORP Delisted | — | United States of America | — | 26 |
| Allelix Biopharmaceuticals Inc. Delisted | ALX | Canada | — | 25 |
| ARIUS Research Inc. Delisted | ARI | Canada | — | 25 |
| Syros Pharmaceuticals, Inc. | 0LC7 | United States of America | — | 25 |
| CliniChem Development Inc. Delisted | CCHE | Canada | — | 23 |
| Gracell Biotechnologies Inc. | GRCL | United States of America | — | 23 |
| Intelligene Inc. | 7832 | Taiwan | — | 23 |
| SEQUANA THERAPEUTICS INC Delisted | — | United States of America | — | 23 |
| SL Science Holding Ltd | — | Cayman Islands | — | 23 |
| SOMATOGEN INC Delisted | — | United States of America | — | 23 |
| Summit Therapeutics plc Delisted | SUMM | United Kingdom | — | 23 |
| Alpine Immune Sciences Inc Delisted | ALPN | United States of America | — | 22 |
| Minster Pharmaceuticals Delisted | — | United Kingdom | — | 22 |
| Mirati Ther Delisted | MRTX | United States of America | — | 22 |
Other names for this activity, and where neighboring activities go instead.
preclinicaldrug developer
Research-led company whose approved medicines, which it discovered, are in one or two therapeutic areas; it moves to Branded Prescription Drugs only after two consecutive annual reports with approved products in three or more.
https://financialfilings.com/oics/CLB/
This page is keyed by the class ID CLB. IDs are assigned in v0.3 and freeze at v1.0; from then on an ID is never renamed or reused, and if the class moves in the tree, its ID and this URL stay the same.
Sign in or create a free account - no password needed.
By continuing, you agree to our Terms and Privacy Policy.